Pablo Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pablo Santos has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Eva Johanna Kantelhardt
Global and Planetary Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
49 shared publications - Barbara Seliger
Martin Luther University Halle-Wittenberg
47 shared publications - Marcus Bauer
Institute of Pathology, University Hospital Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
47 shared publications - Martina Vetter
Department of Gynaecology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
47 shared publications - Ahmedin Jemal
Surveillance, Prevention, and Health Services Research American Cancer Society Atlanta Georgia USA
46 shared publications - Angelica A. Anele
Department of Surgery, Federal Medical Centre , Owerri
46 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Wolters Kluwer Health in Environmental Epidemiology
- Vol. 10 (6) , e539
Urban heat radiation and health perception in Addis Ababa
Background: Exposure to high temperatures poses a multidimensional health hazard. Low- and middle-income countries are likely to experience large increases in average annual temperature due to climate change. Ethiopia is expected to warm by up to 4 °C by 2100. We investigated the association between land surface temperature (LST) and health-related quality of life (HRQOL). This is, to our knowledge, one of the first studies of its kind to be conducted in a large African urban cohort. Methods: We analyzed cross-sectional data from the COMBAT cohort in Addis Ababa, Ethiopia, collected in January 2025 (N = 3201). HRQOL was assessed using the EQ-5D-5L; the outcome variables were the utility index and its five dimensions. LST exposure was characterized using baseline and proximal metrics. We used a beta-one-inflated regression and logistic regression to assess associations. Results: Overall, 53.6% of participants reported problems in at least one EQ-5D-5L dimension, with anxiety or depression being the most frequent (33.5%). Individuals reporting problems were exposed to a slightly higher median baseline LST (32.73 vs. 32.43 °C). We observed a consistent inverted U-shaped association between LST and the probability of reporting perfect health. The probability of reporting problems increased at higher LST values in usual activities, self-care, and anxiety or depression. Conclusion: The results suggest that deviations from the local thermal average are negatively associated with perceived health. This study illustrates the potential value of integrating HRQOL indicators into public health surveillance to enable timely intervention against the health impacts of climate change.
- 18 November 2026
- Published by Wolters Kluwer Health in Environmental Epidemiology
- Vol. 10 (6) , e539
Open AccessUrban heat radiation and health perception in Addis Ababa
Background: Exposure to high temperatures poses a multidimensional health hazard. Low- and middle-income countries are likely to experience large increases in average annual temperature due to climate change. Ethiopia is expected to warm by up to 4 °C by 2100. We investigated the association between land surface temperature (LST) and health-related quality of life (HRQOL). This is, to our knowledge, one of the first studies of its kind to be conducted in a large African urban cohort. Methods: We analyzed cross-sectional data from the COMBAT cohort in Addis Ababa, Ethiopia, collected in January 2025 (N = 3201). HRQOL was assessed using the EQ-5D-5L; the outcome variables were the utility index and its five dimensions. LST exposure was characterized using baseline and proximal metrics. We used a beta-one-inflated regression and logistic regression to assess associations. Results: Overall, 53.6% of participants reported problems in at least one EQ-5D-5L dimension, with anxiety or depression being the most frequent (33.5%). Individuals reporting problems were exposed to a slightly higher median baseline LST (32.73 vs. 32.43 °C). We observed a consistent inverted U-shaped association between LST and the probability of reporting perfect health. The probability of reporting problems increased at higher LST values in usual activities, self-care, and anxiety or depression. Conclusion: The results suggest that deviations from the local thermal average are negatively associated with perceived health. This study illustrates the potential value of integrating HRQOL indicators into public health surveillance to enable timely intervention against the health impacts of climate change.
- Open Access
- 20 May 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (8)
Access and time to chemotherapy among Ethiopian cancer patients: A population-based registry study
Background: Chemotherapy is an essential component of comprehensive cancer care and timely access can improve survival outcomes. The objective of this study was to assess the time to chemotherapy initiation and patient-reported barriers to cancer care among patients from Addis Ababa, Ethiopia. Methods: We conducted a retrospective study using a randomly selected sample of 350 patients with common cancers (breast [ICD-10: C50], cervical [C53], colorectal [C18-20], oesophageal [C15], gastric [C16] and ovarian [C56]) registered at the population-based Addis Ababa City Cancer Registry (AACCR) in 2021. Patients or their relatives were followed-up via questionnaire-based telephone interview and treatment data were extracted from their medical records. The time from pathological diagnosis to initiation of chemotherapy (time to treatment) was calculated. Regression analyses were conducted to identify predictors of chemotherapy initiation and treatment delays. Results: Most patients (71.7%) received chemotherapy and the median time to treatment was 63 days (IQR 36.5 to 128 days). Patients reported considerable barriers to treatment regarding fear, cost and waiting times. Having health insurance (OR 2.70; 95% CI 1.33 to 5.50) and trust in healthcare professionals (OR 1.76; 95% CI 1.16 to 2.68) were associated with higher odds of receiving chemotherapy. Patients with cervical (OR 0.07; 95% CI 0.03 to 0.18), gastric (OR 0.21; 95% CI 0.05 to 0.86) or oesophageal cancer (OR 0.10; 95% CI 0.02 to 0.53) were less likely to initiate chemotherapy compared to breast cancer patients. Longer time to treatment was not associated with any of the assessed characteristics or perceived barriers. Conclusion: Over half of the cancer patients from Addis Ababa wait more than two months to initiate chemotherapy after a pathological diagnosis. Expanding oncology services and health insurance coverage could enhance access to treatment. Health professionals should promote patient trust by appropriately addressing their psychosocial needs, including cancer-related fear, to improve the uptake of treatment and thus clinical outcomes. Implications for practice: Improving access to timely chemotherapy requires coordinated action across multiple levels. Strengthening health system capacity and care coordination is essential to reduce delays, while improving provider-patient communication and integrating psychosocial support can address fear and enhance treatment uptake and adherence. Expanding health insurance coverage may reduce financial barriers but must be accompanied by increased service availability to be effective.
- 20 May 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (8)
Open AccessAccess and time to chemotherapy among Ethiopian cancer patients: A population-based registry study
Background: Chemotherapy is an essential component of comprehensive cancer care and timely access can improve survival outcomes. The objective of this study was to assess the time to chemotherapy initiation and patient-reported barriers to cancer care among patients from Addis Ababa, Ethiopia. Methods: We conducted a retrospective study using a randomly selected sample of 350 patients with common cancers (breast [ICD-10: C50], cervical [C53], colorectal [C18-20], oesophageal [C15], gastric [C16] and ovarian [C56]) registered at the population-based Addis Ababa City Cancer Registry (AACCR) in 2021. Patients or their relatives were followed-up via questionnaire-based telephone interview and treatment data were extracted from their medical records. The time from pathological diagnosis to initiation of chemotherapy (time to treatment) was calculated. Regression analyses were conducted to identify predictors of chemotherapy initiation and treatment delays. Results: Most patients (71.7%) received chemotherapy and the median time to treatment was 63 days (IQR 36.5 to 128 days). Patients reported considerable barriers to treatment regarding fear, cost and waiting times. Having health insurance (OR 2.70; 95% CI 1.33 to 5.50) and trust in healthcare professionals (OR 1.76; 95% CI 1.16 to 2.68) were associated with higher odds of receiving chemotherapy. Patients with cervical (OR 0.07; 95% CI 0.03 to 0.18), gastric (OR 0.21; 95% CI 0.05 to 0.86) or oesophageal cancer (OR 0.10; 95% CI 0.02 to 0.53) were less likely to initiate chemotherapy compared to breast cancer patients. Longer time to treatment was not associated with any of the assessed characteristics or perceived barriers. Conclusion: Over half of the cancer patients from Addis Ababa wait more than two months to initiate chemotherapy after a pathological diagnosis. Expanding oncology services and health insurance coverage could enhance access to treatment. Health professionals should promote patient trust by appropriately addressing their psychosocial needs, including cancer-related fear, to improve the uptake of treatment and thus clinical outcomes. Implications for practice: Improving access to timely chemotherapy requires coordinated action across multiple levels. Strengthening health system capacity and care coordination is essential to reduce delays, while improving provider-patient communication and integrating psychosocial support can address fear and enhance treatment uptake and adherence. Expanding health insurance coverage may reduce financial barriers but must be accompanied by increased service availability to be effective.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Supplementary Figure 2 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Supplementary Figure 2 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S6: Multivariate Cox regression analysis of patient's survival.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S6: Multivariate Cox regression analysis of patient's survival.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S1: Consort diagram of the analyzed samples
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S1: Consort diagram of the analyzed samples
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S5: MHC I expression in SSA
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S5: MHC I expression in SSA
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S4:PD-L1 expression and cytotoxicity
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa
Figure S4:PD-L1 expression and cytotoxicity